Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Pulse Pharmaceuticals
Entity

Pulse Pharmaceuticals

Tracked across 1 events · 6 articles · First seen Aug 20, 2026 · Last active Aug 21, 2026

Sentiment
80
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 80
Regulatory
Pulse Pharmaceuticals gets DCGI approval for nano Vitamin D3
Pulse Pharmaceuticals, a Hyderabad-based nano pharmaceutical drug delivery company, received approval from the India — Drugs Controller General of India (DCGI) for its nano-carrier entrapped Vitamin D3 oral dispersion. The approval, announced on August 20,…
Impact: Received DCGI approval for its nano-carrier Vitamin D3 product, a major milestone that validates its Aqueol platform and could drive future revenue growth and global expansion.
Aug 20, 2026 · 6 articles
Key Actions (2)
100 Pulse Pharmaceuticals received approvalPulse Pharmaceuticals gets...
100 India — Drugs Controller General of India approved Pulse PharmaceuticalsPulse Pharmaceuticals gets...
ERGEN INTELLIGENCE
Track Pulse Pharmaceuticals live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.